Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2023

Oct 31, 2023

5250_mrq_2023-10-31_bef75b92-d2cf-48aa-beab-d60c8484273a.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 8906R

Barclays PLC

31 October 2023

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose DECHRA PHARMACEUTICALS PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 30 Oct 2023
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security: 1p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 7,511,421 6.60% 2,803,259 2.46%
(2) Cash-settled derivatives:
and/or controlled: 1,311,213 1.15% 7,419,159 6.51%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 8,822,634 7.75% 10,222,418 8.98%
(b) Rights to subscribe for new securities (including directors and other executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
1p ordinary Purchase 23,515 37.8860  GBP
1p ordinary Purchase 21,485 38.0000  GBP
1p ordinary Purchase 6,502 37.8187  GBP
1p ordinary Purchase 4,769 37.8893  GBP
1p ordinary Purchase 2,816 37.9131  GBP
1p ordinary Purchase 1,852 37.8817  GBP
1p ordinary Purchase 918 37.8679  GBP
1p ordinary Purchase 839 37.8950  GBP
1p ordinary Purchase 693 37.9019  GBP
1p ordinary Purchase 544 37.9061  GBP
1p ordinary Purchase 515 37.8658  GBP
1p ordinary Purchase 440 37.8904  GBP
1p ordinary Purchase 385 37.8600  GBP
1p ordinary Purchase 334 37.8737  GBP
1p ordinary Purchase 260 37.9079  GBP
1p ordinary Purchase 203 37.9000  GBP
1p ordinary Purchase 119 37.8075  GBP
1p ordinary Sale 8,504 37.9580  GBP
1p ordinary Sale 5,800 37.9971  GBP
1p ordinary Sale 4,678 38.0000  GBP
1p ordinary Sale 1,441 37.8990  GBP
1p ordinary Sale 1,369 37.8609  GBP
1p ordinary Sale 506 37.8176  GBP
1p ordinary Sale 385 37.8600  GBP
1p ordinary Sale 296 37.8014  GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
1p ordinary CFD Long 385 37.8600  GBP
1p ordinary SWAP Long 506 37.8176  GBP
1p ordinary SWAP Long 1,441 37.8990  GBP
1p ordinary SWAP Long 2,346 37.8634  GBP
1p ordinary SWAP Long 5,800 37.9971  GBP
1p ordinary SWAP Long 7,438 37.9688  GBP
1p ordinary SWAP Short 1 38.0038  GBP
1p ordinary CFD Short 119 37.8075  GBP
1p ordinary SWAP Short 693 37.9019  GBP
1p ordinary SWAP Short 1,422 37.9046  GBP
1p ordinary CFD Short 2,816 37.9131  GBP
1p ordinary SWAP Short 2,992 37.9932  GBP
1p ordinary SWAP Short 5,098 38.0000  GBP
1p ordinary SWAP Short 6,502 37.8187  GBP
1p ordinary CFD Short 7,467 37.8780  GBP
1p ordinary SWAP Short 8,202 37.8930  GBP
1p ordinary CFD Short 12,710 38.0000  GBP
1p ordinary SWAP Short 13,494 37.8883  GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 31 Oct 2023
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETEAFEFDDPDFFA